Pharmaceutical composition which improves in vivo gene transfer
US7709452B2 · kind B2 · utility
50Cited by
2References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 7, 2003 |
| Grant date | May 4, 2010 |
| Priority date | — |
| Expiry date | Jul 6, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a pharmaceutical composition which combines a tetrafunctional copolymer with a nucleic acid, said copolymer having formula I (namely a poloxamine), and preferably taking the form of one of the cationic mineral or organic salts thereof. The inventive composition can be used to improve in vivo gene transfer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.